Trust Company of Oklahoma’s Edwards Lifesciences EW Stock Holding History

Trust Company of Oklahoma’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$347K	Buy	3,839 +337	+10%	+$28.2K	0.09%	112
2026 Q1	$280K	Buy	3,502 +27	+0.8%	+$2.23K	0.08%	119
2025 Q4	$296K	Sell	3,475 -436	-11%	-$35.8K	0.09%	110
2025 Q3	$304K	Sell	3,911 -215	-5%	-$16.8K	0.09%	113
2025 Q2	$323K	Buy	4,126 +120	+3%	+$8.95K	0.1%	109
2025 Q1	$290K	Sell	4,006 -809	-17%	-$57.9K	0.1%	106
2024 Q4	$356K	Sell	4,815 -2,840	-37%	-$199K	0.11%	105
2024 Q3	$505K	Buy	7,655 +1,993	+35%	+$145K	0.16%	89
2024 Q2	$523K	Buy	5,662 +2,541	+81%	+$225K	0.18%	91
2024 Q1	$298K	Buy	+3,121	New	+$262K	0.11%	116

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

BHIA

Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return

NONA

Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

SIM

Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Trust Company of Oklahoma's EW Position: Q2 2026 in Review

Trust Company of Oklahoma increased its Edwards Lifesciences (EW) stake by 9.6% in Q2 2026, buying an estimated $28.2K and bringing the position to 3,839 shares worth $347K. The position accounts for 0.09% of the portfolio, ranked #112.

Trust Company of Oklahoma first reported a position in EW in Q1 2024 and has held it in 10 quarters since. The position peaked at $523K in Q2 2024. 458 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Trust Company of Oklahoma held 3,839 shares of Edwards Lifesciences worth $347K as of Q2 2026.
Trust Company of Oklahoma bought 337 Edwards Lifesciences shares in Q2 2026, an estimated $28.2K.
Edwards Lifesciences made up 0.09% of Trust Company of Oklahoma's portfolio in Q2 2026, its #112 holding.
Trust Company of Oklahoma first reported a position in Edwards Lifesciences in Q1 2024 and has held it in 10 quarters since.
Trust Company of Oklahoma's Edwards Lifesciences position peaked at $523K in Q2 2024.
458 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Trust Company of Oklahoma's 13F filing for Q2 2026, filed 14 Jul 2026.